Invex Therapeutics (Australia) Market Value
| IXC Stock | 0.07 0.01 7.46% |
| Symbol | Invex |
Invex Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Invex Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Invex Therapeutics.
| 11/11/2024 |
| 12/11/2024 |
If you would invest 0.00 in Invex Therapeutics on November 11, 2024 and sell it all today you would earn a total of 0.00 from holding Invex Therapeutics or generate 0.0% return on investment in Invex Therapeutics over 30 days. Invex Therapeutics is related to or competes with Aurelia Metals, Perseus Mining, and Home Consortium. Invex Therapeutics is entity of Australia More
Invex Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Invex Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Invex Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.76 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 27.99 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 6.17 |
Invex Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Invex Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Invex Therapeutics' standard deviation. In reality, there are many statistical measures that can use Invex Therapeutics historical prices to predict the future Invex Therapeutics' volatility.| Risk Adjusted Performance | 0.0288 | |||
| Jensen Alpha | 0.03 | |||
| Total Risk Alpha | (0.45) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.1725 |
Invex Therapeutics Backtested Returns
Currently, Invex Therapeutics is out of control. Invex Therapeutics holds Efficiency (Sharpe) Ratio of 0.0294, which attests that the entity had a 0.0294% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Invex Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Invex Therapeutics' Market Risk Adjusted Performance of 0.1825, downside deviation of 5.76, and Risk Adjusted Performance of 0.0288 to validate if the risk estimate we provide is consistent with the expected return of 0.1%. Invex Therapeutics has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.52, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Invex Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Invex Therapeutics is expected to be smaller as well. Invex Therapeutics right now retains a risk of 3.47%. Please check out Invex Therapeutics sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Invex Therapeutics will be following its current trending patterns.
Auto-correlation | -0.7 |
Very good reverse predictability
Invex Therapeutics has very good reverse predictability. Overlapping area represents the amount of predictability between Invex Therapeutics time series from 11th of November 2024 to 26th of November 2024 and 26th of November 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Invex Therapeutics price movement. The serial correlation of -0.7 indicates that around 70.0% of current Invex Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.79 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Invex Therapeutics lagged returns against current returns
Autocorrelation, which is Invex Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Invex Therapeutics' stock expected returns. We can calculate the autocorrelation of Invex Therapeutics returns to help us make a trade decision. For example, suppose you find that Invex Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Invex Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Invex Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Invex Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Invex Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Invex Therapeutics Lagged Returns
When evaluating Invex Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Invex Therapeutics stock have on its future price. Invex Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Invex Therapeutics autocorrelation shows the relationship between Invex Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Invex Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Invex Stock Analysis
When running Invex Therapeutics' price analysis, check to measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.